|
Back to Home » January 2012 News » Lpath Temporarily Suspends Dosing of iSONEP in Clinical Trials Due to cGMP Compliance Issues at Contract Fill/Finish Source |
Lpath Temporarily Suspends Dosing of iSONEP in Clinical Trials Due to cGMP Compliance Issues at Contract Fill/Finish Source |
January 26, 2012
Management to Host Investor Conference Call Tomorrow, Friday, January 27 at 8:45 a.m. ET
Source URL: http://www.marketwire.com/mw/release.do?id=1611710&sourceType=3
|
|
|
|
